Universal Health Financials
This page shows Universal Health (UHT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Universal Health has an operating margin of 37.2%, meaning the company retains $37 of operating profit per $100 of revenue. This strong profitability earns a score of 100/100, reflecting efficient cost management and pricing power. This is up from 32.8% the prior year.
Universal Health's revenue grew a modest 3.6% year-over-year to $99.0M. This slow but positive growth earns a score of 39/100.
Universal Health has a moderate D/E ratio of 2.05. This balance of debt and equity financing earns a leverage score of 35/100.
Universal Health's ROE of 10.7% shows moderate profitability relative to equity, earning a score of 43/100. This is up from 7.7% the prior year.
Universal Health passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Universal Health generates $2.44 in operating cash flow ($46.9M OCF vs $19.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Universal Health earns $2.0 in operating income for every $1 of interest expense ($36.8M vs $18.8M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Universal Health generated $99.0M in revenue in fiscal year 2024. This represents an increase of 3.6% from the prior year.
Universal Health's EBITDA was $64.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.7% from the prior year.
Universal Health reported $19.2M in net income in fiscal year 2024. This represents an increase of 24.9% from the prior year.
Universal Health earned $1.39 per diluted share (EPS) in fiscal year 2024. This represents an increase of 25.2% from the prior year.
Universal Health held $7.1M in cash against $368.4M in long-term debt as of fiscal year 2024.
Universal Health paid $2.92 per share in dividends in fiscal year 2024. This represents an increase of 1.4% from the prior year.
Universal Health had 14M shares outstanding in fiscal year 2024. This represents an increase of 0.2% from the prior year.
Universal Health's operating margin was 37.2% in fiscal year 2024, reflecting core business profitability. This is up 4.4 percentage points from the prior year.
Universal Health's net profit margin was 19.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 3.3 percentage points from the prior year.
Universal Health's ROE was 10.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 3.0 percentage points from the prior year.
UHT Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.3M+1.7% | $24.9M+1.3% | $24.5M+0.9% | $24.3M+0.4% | $24.2M+1.8% | $23.8M+2.5% | $23.2M-3.7% | $24.1M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $8.4M-5.1% | $8.8M-2.1% | $9.0M+10.8% | $8.2M+1.6% | $8.0M+8.7% | $7.4M-5.2% | $7.8M-10.8% | $8.7M |
| Interest Expense | -$4.8M-2.1% | -$4.7M-1.0% | -$4.7M-1.9% | -$4.6M-2.6% | -$4.5M-7.0% | -$4.2M-13.0% | -$3.7M-10.5% | -$3.3M |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | $4.0M-10.6% | $4.5M-6.0% | $4.8M+33.0% | $3.6M-7.2% | $3.9M+11.4% | $3.5M-22.0% | $4.5M-20.8% | $5.6M |
| EPS (Diluted) | $0.29-9.4% | $0.32-5.9% | $0.34+30.8% | $0.26-7.1% | $0.28+12.0% | $0.25-21.9% | $0.32-22.0% | $0.41 |
UHT Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $568.0M-0.9% | $573.0M-0.1% | $573.5M-3.8% | $596.4M-1.9% | $607.9M+0.8% | $603.0M-0.2% | $604.3M-0.5% | $607.5M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $6.9M+5.5% | $6.6M-6.0% | $7.0M-15.1% | $8.2M-1.8% | $8.4M-11.6% | $9.5M+16.5% | $8.1M+6.6% | $7.6M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $409.5M+0.4% | $407.9M+1.6% | $401.3M+1.5% | $395.4M-0.5% | $397.6M+2.9% | $386.3M+1.1% | $382.1M+1.0% | $378.4M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $368.4M | N/A | N/A | $359.7M | N/A | N/A | N/A | $343.1M |
| Total Equity | $158.6M-4.0% | $165.2M-4.1% | $172.2M-14.3% | $200.9M-4.5% | $210.3M-2.9% | $216.6M-2.5% | $222.2M-3.0% | $229.1M |
| Retained Earnings | $858.6M+0.5% | $854.6M+0.5% | $850.1M+2.9% | $826.1M+0.4% | $822.5M+0.5% | $818.6M+0.4% | $815.1M+0.6% | $810.7M |
UHT Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.2M-25.5% | $13.7M+17.9% | $11.6M+11.1% | $10.5M+2.9% | $10.2M-17.1% | $12.3M+21.7% | $10.1M-18.1% | $12.3M |
| Capital Expenditures | N/A | N/A | N/A | $22K | N/A | N/A | N/A | $0 |
| Free Cash Flow | N/A | N/A | N/A | $10.4M | N/A | N/A | N/A | $12.3M |
| Investing Cash Flow | -$1.8M+80.1% | -$8.8M-363.2% | -$1.9M-358.1% | $735K+106.7% | -$11.0M-214.7% | -$3.5M+35.6% | -$5.4M+0.4% | -$5.4M |
| Financing Cash Flow | -$8.1M-52.0% | -$5.3M+45.9% | -$9.8M+13.2% | -$11.3M-3604.9% | -$306K+95.9% | -$7.4M-79.0% | -$4.2M+43.5% | -$7.3M |
| Dividends Paid | $10.3M0.0% | $10.3M+1.5% | $10.2M+1.5% | $10.0M+1.0% | $9.9M-1.0% | $10.0M+1.5% | $9.9M0.0% | $9.9M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
UHT Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'23 | Q3'24 | Q2'24 | Q1'24 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 33.2%-2.4pp | 35.6%-1.2pp | 36.8%+3.3pp | 33.5%+0.4pp | 33.1%+2.1pp | 31.0%-2.5pp | 33.5%-2.7pp | 36.2% |
| Net Margin | 15.9%-2.2pp | 18.1%-1.4pp | 19.5%+4.7pp | 14.8%-1.2pp | 16.0%+1.4pp | 14.6%-4.6pp | 19.2%-4.1pp | 23.3% |
| Return on Equity | 2.5%-0.2pp | 2.7%-0.1pp | 2.8%+1.0pp | 1.8%-0.1pp | 1.8%+0.2pp | 1.6%-0.4pp | 2.0%-0.5pp | 2.5% |
| Return on Assets | 0.7%-0.1pp | 0.8%-0.1pp | 0.8%+0.2pp | 0.6%-0.0pp | 0.6%+0.1pp | 0.6%-0.2pp | 0.7%-0.2pp | 0.9% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 2.58+0.1 | 2.47+0.1 | 2.33+0.5 | 1.79-0.1 | 1.89+0.1 | 1.78+0.1 | 1.72+0.2 | 1.50 |
| FCF Margin | N/A | N/A | N/A | 42.9% | N/A | N/A | N/A | 50.9% |
Similar Companies
Frequently Asked Questions
What is Universal Health's annual revenue?
Universal Health (UHT) reported $99.0M in total revenue for fiscal year 2024. This represents a 3.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Universal Health's revenue growing?
Universal Health (UHT) revenue grew by 3.6% year-over-year, from $95.6M to $99.0M in fiscal year 2024.
Is Universal Health profitable?
Yes, Universal Health (UHT) reported a net income of $19.2M in fiscal year 2024, with a net profit margin of 19.4%.
What is Universal Health's earnings per share (EPS)?
Universal Health (UHT) reported diluted earnings per share of $1.39 for fiscal year 2024. This represents a 25.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Universal Health's EBITDA?
Universal Health (UHT) had EBITDA of $64.2M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Universal Health have?
As of fiscal year 2024, Universal Health (UHT) had $7.1M in cash and equivalents against $368.4M in long-term debt.
What is Universal Health's operating margin?
Universal Health (UHT) had an operating margin of 37.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Universal Health's net profit margin?
Universal Health (UHT) had a net profit margin of 19.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Does Universal Health pay dividends?
Yes, Universal Health (UHT) paid $2.92 per share in dividends during fiscal year 2024.
What is Universal Health's return on equity (ROE)?
Universal Health (UHT) has a return on equity of 10.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Universal Health's operating cash flow?
Universal Health (UHT) generated $46.9M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Universal Health's total assets?
Universal Health (UHT) had $580.9M in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Universal Health have outstanding?
Universal Health (UHT) had 14M shares outstanding as of fiscal year 2024.
What is Universal Health's debt-to-equity ratio?
Universal Health (UHT) had a debt-to-equity ratio of 2.05 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Universal Health's return on assets (ROA)?
Universal Health (UHT) had a return on assets of 3.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Universal Health's Piotroski F-Score?
Universal Health (UHT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Universal Health's earnings high quality?
Universal Health (UHT) has an earnings quality ratio of 2.44x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Universal Health cover its interest payments?
Universal Health (UHT) has an interest coverage ratio of 2.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Universal Health?
Universal Health (UHT) scores 54 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.